Literature DB >> 22832163

miR-511-3p modulates genetic programs of tumor-associated macrophages.

Mario Leonardo Squadrito1, Ferdinando Pucci, Laura Magri, Davide Moi, Gregor D Gilfillan, Anna Ranghetti, Andrea Casazza, Massimiliano Mazzone, Robert Lyle, Luigi Naldini, Michele De Palma.   

Abstract

Expression of the mannose receptor (MRC1/CD206) identifies macrophage subtypes, such as alternatively activated macrophages (AAMs) and M2-polarized tumor-associated macrophages (TAMs), which are endowed with tissue-remodeling, proangiogenic, and protumoral activity. However, the significance of MRC1 expression for TAM's protumoral activity is unclear. Here, we describe and characterize miR-511-3p, an intronic microRNA (miRNA) encoded by both mouse and human MRC1 genes. By using sensitive miRNA reporter vectors, we demonstrate robust expression and bioactivity of miR-511-3p in MRC1(+) AAMs and TAMs. Unexpectedly, enforced expression of miR-511-3p tuned down the protumoral gene signature of MRC1(+) TAMs and inhibited tumor growth. Our findings suggest that transcriptional activation of Mrc1 in TAMs evokes a genetic program orchestrated by miR-511-3p, which limits rather than enhances their protumoral functions. Besides uncovering a role for MRC1 as gatekeeper of TAM's protumoral genetic programs, these observations suggest that endogenous miRNAs may operate to establish thresholds for inflammatory cell activation in tumors.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832163     DOI: 10.1016/j.celrep.2011.12.005

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  86 in total

1.  MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model.

Authors:  L Yu; Q Liao; X Zeng; Z Lv; H Zheng; Y Zhao; X Sun; Z Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-30       Impact factor: 3.267

Review 2.  Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.

Authors:  Nazila Nouraee; Seyed Javad Mowla; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2015-03-31       Impact factor: 5.006

3.  Rewiring macrophages for anti-tumour immunity.

Authors:  Yunqin Lee; Subhra K Biswas
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

Review 4.  Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis.

Authors:  Massimiliano Mazzone; Gabriele Bergers
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

Review 5.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

6.  A niche role for periostin and macrophages in glioblastoma.

Authors:  Mario Leonardo Squadrito; Michele De Palma
Journal:  Nat Cell Biol       Date:  2015-02       Impact factor: 28.824

Review 7.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

8.  miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.

Authors:  Danh C Do; Jie Mu; Xia Ke; Karan Sachdeva; Zili Qin; Mei Wan; Faoud T Ishmael; Peisong Gao
Journal:  JCI Insight       Date:  2019-10-17

Review 9.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

Review 10.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.